Table 2 treatment characteristics
| Â | RT-group | S-group |
|---|---|---|
RT axilla (%) | 100% | 5.9% |
RT internal mammary chain (%) | 78.3% | 23.2% |
Tamoxifen (%) | 98.9% | 22.3% |
Chemotherapy (%) | 0.6% | 10.0% |
| Â | RT-group | S-group |
|---|---|---|
RT axilla (%) | 100% | 5.9% |
RT internal mammary chain (%) | 78.3% | 23.2% |
Tamoxifen (%) | 98.9% | 22.3% |
Chemotherapy (%) | 0.6% | 10.0% |